Apotex Health Corp. reports a second-quarter profit of $100.8 million and raises its guidance for full-year revenue growth. The company says the profit is higher than the $82.9 million it reported for the same quarter a year earlier.
Apotex’s reporting also includes second-quarter revenue of $852.9 million, up from $843.5 million in the comparable quarter last year. Both outlets describe the guidance increase, though only the overall direction is emphasized in the summaries provided. The coverage largely aligns on the core financial results—profit, revenue, and the updated outlook for the year—without highlighting differing interpretations beyond what each outlet chooses to foreground.